132 related articles for article (PubMed ID: 28690120)
1. The prognosis outcome of oral squamous cell carcinoma using HIF-2α.
Lim E; Kuo CC; Tu HF; Yang CC
J Chin Med Assoc; 2017 Oct; 80(10):651-656. PubMed ID: 28690120
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia inducible factor: a potential prognostic biomarker in oral squamous cell carcinoma.
Qian J; Wenguang X; Zhiyong W; Yuntao Z; Wei H
Tumour Biol; 2016 Aug; 37(8):10815-20. PubMed ID: 26880584
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
[TBL] [Abstract][Full Text] [Related]
4. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.
Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C
Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892
[TBL] [Abstract][Full Text] [Related]
5. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
[TBL] [Abstract][Full Text] [Related]
6. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
7. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
[TBL] [Abstract][Full Text] [Related]
8. The correlation between HIF-1 alpha and VEGF in oral squamous cell carcinomas: Expression patterns and quantitative immunohistochemical analysis.
Lee LT; Wong YK; Chan MY; Chang KW; Chen SC; Chang CT; Wang J
J Chin Med Assoc; 2018 Apr; 81(4):370-375. PubMed ID: 29289482
[TBL] [Abstract][Full Text] [Related]
9. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
[TBL] [Abstract][Full Text] [Related]
10. HIF-2α not HIF-1α overexpression confers poor prognosis in non-small cell lung cancer.
Gao ZJ; Wang Y; Yuan WD; Yuan JQ; Yuan K
Tumour Biol; 2017 Jun; 39(6):1010428317709637. PubMed ID: 28653893
[TBL] [Abstract][Full Text] [Related]
11. CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC.
Biswas S; Charlesworth PJ; Turner GD; Leek R; Thamboo PT; Campo L; Turley H; Dildey P; Protheroe A; Cranston D; Gatter KC; Pezzella F; Harris AL
Carcinogenesis; 2012 Sep; 33(9):1717-25. PubMed ID: 22777959
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
13. Prognostic markers in stage I oral cavity squamous cell carcinoma.
Dunkel J; Vaittinen S; Grénman R; Kinnunen I; Irjala H
Laryngoscope; 2013 Oct; 123(10):2435-41. PubMed ID: 23918741
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma.
Liang X; Zheng M; Jiang J; Zhu G; Yang J; Tang Y
Oral Oncol; 2011 Feb; 47(2):92-7. PubMed ID: 21167768
[TBL] [Abstract][Full Text] [Related]
15. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J
Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of HIF-1α and HIF-2α expression in small cell lung cancer.
Luan Y; Gao C; Miao Y; Li Y; Wang Z; Qiu X
Pathol Res Pract; 2013 Mar; 209(3):184-9. PubMed ID: 23375698
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients.
Beasley NJ; Leek R; Alam M; Turley H; Cox GJ; Gatter K; Millard P; Fuggle S; Harris AL
Cancer Res; 2002 May; 62(9):2493-7. PubMed ID: 11980639
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression.
Tatli Dogan H; Kiran M; Bilgin B; Kiliçarslan A; Sendur MAN; Yalçin B; Ardiçoglu A; Atmaca AF; Gumuskaya B
Diagn Pathol; 2018 Aug; 13(1):60. PubMed ID: 30144808
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive values of SPP1, PAI and caveolin-1 in patients with oral squamous cell carcinoma.
Huang CF; Yu GT; Wang WM; Liu B; Sun ZJ
Int J Clin Exp Pathol; 2014; 7(9):6032-9. PubMed ID: 25337248
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]